Your browser doesn't support javascript.
loading
Patient Preferences for Benefits, Risks, and Administration Route of Hypomethylating Agents in Myelodysplastic Syndromes.
Zeidan, Amer M; Tsai, Jui-Hua; Karimi, Milad; Schmier, Jordana; Jayade, Sayeli; Zormpas, Evangelos; Hassan, Audrey; Ruiters, Desiree; Anthony, Cindy; Hill, Kala; Wert, Tim; Botteman, Marc.
  • Zeidan AM; Section of Hematology, Department of Medicine, Yale School of Medicine, and Yale Cancer Center, New Haven, CT. Electronic address: Amer.zeidan@yale.edu.
  • Tsai JH; OPEN Health, Bethesda, MD.
  • Karimi M; OPEN Health, Rotterdam, The Netherlands.
  • Schmier J; OPEN Health, Bethesda, MD.
  • Jayade S; OPEN Health, Bethesda, MD.
  • Zormpas E; OPEN Health, Enterprise House, York, United Kingdom.
  • Hassan A; The Myelodysplastic Syndromes (MDS) Foundation, Yardville, NJ.
  • Ruiters D; Aplastic Anemia and MDS International Foundation, Bethesda, MD.
  • Anthony C; Aplastic Anemia and Myelodysplasia Association of Canada (AAMAC), King City, Ontario, Canada.
  • Hill K; Taiho Oncology, Princeton, NJ.
  • Wert T; Taiho Oncology, Princeton, NJ.
  • Botteman M; OPEN Health, Bethesda, MD.
Clin Lymphoma Myeloma Leuk ; 22(9): e853-e866, 2022 09.
Article en En | MEDLINE | ID: mdl-35729009
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Prioridad del Paciente Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male País como asunto: America do norte Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Prioridad del Paciente Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male País como asunto: America do norte Idioma: En Año: 2022 Tipo del documento: Article